COMMUNIQUÉS West-GlobeNewswire

ERYTECH présente de nouveaux résultats précliniques avec erymethionase au congrès de l’AACR 2019
01/04/2019
Ces résultats démontrent le potentiel de l'association d’erymethionase avec l'inhibition des points de contrôle immunitaires LYON, France, 01 avr. 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris : ERYP - Nasdaq [...]
EB Research Partnership Announces the 3rd Annual Believe in Brady on April 7 in Houston
01/04/2019
Annual Event at Levy Park Conservancy for “Butterfly Children” with the Life-Threatening Skin Disease Epidermolysis Bullosa HOUSTON, April 01, 2019 (GLOBE NEWSWIRE) -- EB Research Partnership (EBRP), the largest [...]
Initial Results from Autolus Therapeutics’ ALLCAR19 Phase 1/2 Trial in Adult Acute Lymphoblastic Leukemia Presented at the AACR Annual Meeting
01/04/2019
Initial results from the trial show 88% molecular complete response at one month with well-tolerated safety profile Management to Hold Conference Call on April 2, 2019 at 8:00am ET / 1:00pm BST LONDON, April 01, 2019 ( [...]
Dynavax’s SD-101 and 4SC’s Domatinostat Demonstrate Synergy and Induce a Systemic Anti-tumor Response in Preclinical Models
01/04/2019
BERKELEY, Calif. and PLANEGG-MARTINSRIED, Germany, April 01, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX) and 4SC AG (FSE Prime Standard: VSC) today announced the combination of 4SC’s orally [...]
Aptose Presents New Preclinical Data on CG-806 and APTO-253 at the 2019 AACR Annual Meeting
01/04/2019
Pan-FLT3/pan-BTK inhibitor CG-806 Demonstrates Significant and Superior Potency Against Primary Cells Across AML Types – MYC Inhibitor APTO-253 Potently Kills Hematologic Cell Lines; Mechanism of Action Further Defined [...]
Allogene Therapeutics Presents Preclinical Data Demonstrating the Potential of AlloCAR T™ Therapy in Renal Cell Carcinoma (RCC) at the 2019 AACR Annual Meeting
01/04/2019
Anti-CD70 AlloCAR T™ Could Be Optimized to Eliminate Both CD70 Low and High Expressing Target Cells, and Manufactured in a Large-Scale Process CD70, Present on Both Hematologic Malignancies and Solid Tumors, May [...]
Celldex Presents Promising Data from CDX-527 Bispecific and TAM Receptor Programs at American Association for Cancer Research (AACR) Annual Meeting 2019
01/04/2019
HAMPTON, N.J., April 01, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) presented promising data from the Company’s growing bispecific and TAM (Tyro3, Axl, MerTK) receptor programs during poster [...]
Apollomics, Inc. Presents Positive Preclinical Data on APL-102, an oral Multi-Kinase Inhibitor with CSF-1R Activity
01/04/2019
Activity Demonstrated as a Single Agent and in Combination with an anti-PD-1 antibody FOSTER CITY, Calif. and HANGZHOU, China, April 01, 2019 (GLOBE NEWSWIRE) -- Apollomics, Inc. (the “Company”), an innovative [...]
Constellation Pharmaceuticals Presents Results from Phase 1b Portion of ProSTAR Clinical Trial of CPI-1205 at AACR Meeting
01/04/2019
Clinical activity of CPI-1205 was seen in subsets of advanced metastatic castration-resistant prostate cancer (mCRPC) patients Recently initiated Phase 2 portion of ProSTAR includes randomized testing of CPI-1205 in [...]
Athersys to Participate in Two Upcoming Healthcare Conferences
01/04/2019
CLEVELAND, April 01, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today the Company’s participation in two upcoming biotechnology and healthcare conferences. On April 4 th , Athersys will be part of [...]
American College of Rheumatology Targets Step Therapy and Drug Pricing in New Position Statements
01/04/2019
ATLANTA, April 01, 2019 (GLOBE NEWSWIRE) -- American College of Rheumatology Targets Step Therapy and Drug Pricing in New Position Statements ATLANTA – The American College of Rheumatology (ACR) has released new drug [...]
MicroPulse TSCPC featured in multiple abstracts, posters, presentations and wet lab at the World Glaucoma Congress
01/04/2019
MOUNTAIN VIEW, Calif., April 01, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced [...]
Catalyst Biosciences Receives Orphan Designation from the European Commission for Marzeptacog Alfa (Activated)
01/04/2019
Dosing successfully completed in the Phase 2 portion of the Phase 2/3 MarzAA trial for the treatment of hemophilia A or B with inhibitors SOUTH SAN FRANCISCO, Calif., April 01, 2019 (GLOBE NEWSWIRE) -- Catalyst [...]
Ossur Hf : Transactions in relation to share buyback program
01/04/2019
Announcement no. 22/2019 1 April 2019 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]
CardieX Group Company inHealth CEO & Co-Founder Aubrey Jenkins Secures Position on Prestigious MM&M Top 40 Healthcare Transformers Honor Roll
01/04/2019
Highlights CardieX group Company inHealth Medical Services CEO & Co-Founder Aubrey Jenkins awarded place on MM&M’s 2019 class of Top 40 Healthcare Transformers Honor Roll recognises visionaries, self-starters [...]
Information relative au nombre total de droits de vote et d’actions composant le capital social au 31 mars 2019
01/04/2019
Paris, le 1 er avril 2019 – 18 :00 CET - Pixium Vision (FR0011950641 - PIX), société bioélectronique qui développe des systèmes de vision bionique innovants pour permettre aux patients ayant perdu la vue, de vivre de [...]
Information on total number of voting rights and shares composing the share capital as at March 31st, 2019
01/04/2019
Paris, April 1 st , 2019 – 6.00PM CET - Pixium Vision (FR0011950641 - PIX), a bioelectronic company developing innovative bionic vision systems to allow patients who have lost their sight to lead more independent lives [...]
Taconic Biosciences Licenses the Wild Mouse Gut Microbiome from the National Institute of Diabetes and Digestive and Kidney Diseases
01/04/2019
RENSSELAER, N.Y., April 01, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces it has obtained a license to the Wild Mouse gut microbiome [...]
Resverlogix Cognition Substudy of the BETonMACE Phase 3 Cardiovascular Trial Presented at the International Conference on Alzheimer’s & Parkinson’s Diseases
01/04/2019
CALGARY, Alberta, April 01, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) today announces that Dr. Jeffrey Cummings, Founding Director of the Cleveland Clinic Lou Ruvo Brain [...]

Pages